US Extends Enforcement Discretion For Infant Formula Production With Guidance For Compliance
Guidance extends through Jan. 6 enforcement discretion for formula products cleared for sales under temporary guidance FDA announced in May. Further extensions possible for firms taking steps toward lawful marketing of products in US, agency says.
You may also be interested in...
USDA Food Safety and Inspection Service’s National Advisory Committee on Microbiological Criteria for Foods schedules hearing for 15 November to consider a report from FDA on presence of Cronobacter species bacteria in powder formula products.
FDA “determined a more streamlined pathway” using information it's received for products available under enforcement discretion “would help provide for the long-term availability and marketing of many” of those products.
Latest announcement about recall not reported in SEC filing came in FDA posting of Abbott’s announcement concerning an expansion of firm’s recall to include an additional lot of Similac powder.